Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic Establishes Heart Rhythm Disease Management School In Beijing

This article was originally published in PharmAsia News

Executive Summary

Medtronic recently established a school for heart rhythm disease management and education in Beijing. As part of Medtronic College, the school will provide systematic specialty training for physicians, technicians and relevant healthcare providers in cardiac pacing and electrophysiology from China, Hong Kong and Taiwan. More than 60 local experts have accepted appointments as visiting professors for the school. Medtronic funded and set up China's first corporate college in the healthcare industry as a non-profit training organization to raise doctors' professional and management skills. The college houses 11 schools offering professional education for more than 12,000 physicians in areas such as diabetes management, cardiology, cardiovascular surgery, orthopedics, neural surgery and ENT surgery. (Click here for more - Chinese language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071314

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel